INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Flex Pharma, Inc. & Encourages In...
June 19 2018 - 5:07PM
Business Wire
The Schall Law Firm, a national shareholder rights litigation
firm, announces the filing of a class action lawsuit against Flex
Pharma, Inc. (“Flex Pharma” or ''the Company'') (NASDAQ: FLKS) for
violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities
and Exchange Commission.
Investors who purchased the Company's shares between November 6,
2017, and June 12, 2018, inclusive (the ''Class Period''), are
encouraged to contact the firm before August 20, 2018.
If you are a shareholder who suffered a loss, click here to
participate.
We also encourage you to contact Brian Schall, or Sherin
Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite
404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights
free of charge. You can also reach us through the firm's website
at www.schallfirm.com, or by email
at brian@schallfirm.com.
The class, in this case, has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
According to the Complaint, the Company made false and
misleading statements to the market throughout the class period.
Flex Pharma was overly optimistic regarding the approval chance and
viability of FLX-787, its potential product for the treatment of
ALS and CMT. This resulted in the Company making materially false
and misleading public statements. When the market learned the true
details about Flex Pharma, investors suffered damages.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder
rights litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180619006436/en/
The Schall Law FirmBrian Schall, Esq.,Sherin Mahdavian,
Esq.,www.schallfirm.com310-301-3335info@schallfirm.com
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Jul 2024 to Aug 2024
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Aug 2023 to Aug 2024